Navigation Links
Misonix Announces Extension and Expansion of Distribution Agreement With Mentor Corporation

FARMINGDALE, N.Y., Dec. 10 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced it has extended its distribution agreement for the Lysonix(R) 3000 Ultrasound Assisted Liposuction System with Santa Barbara, CA, based Mentor Corporation for an additional year. Under the terms of the agreement extension, Mentor retains exclusive distribution rights for Lysonix in the U.S. and gains non-exclusive rights for certain foreign markets. Minimum purchase requirements apply to both U.S. and world markets and represent significant growth over the previous year.

Mentor Corporation is a leading supplier of medical product for the global aesthetic market. Mentor develops, manufactures and markets innovative, science-based products for surgical and non-surgical medical procedures that allow patients to retain a youthful appearance while improving personal well-being.

Liposuction is a major product segment within the multi-billion dollar aesthetic procedure market, with the number of procedures in the U.S. exceeding 400,000 per year, as reported by the American Society of Plastic Surgeons. The Lysonix 3000 Ultrasound Assisted Liposuction System provides multiple benefits to both patient and physician versus other liposuction methods, including small incision sites, targeted fat removal, reduced bleeding, reduced bruising, and faster procedure time.

"Misonix is quite pleased to continue our long-term association with Mentor, a major force in the aesthetic surgery market. We look forward to continuing our collaboration in growing the ultrasound assisted liposuction market while exploring other potential applications for this valuable surgical tool," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.

About Misonix:

Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.

    Investor Relations Contact:
    Cameron Associates, Inc.
    Kevin McGrath

SOURCE Misonix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Misonix Reports First Quarter Fiscal Year 2009 Financial Results
2. Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
3. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
4. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
5. Genomma Lab Announces 2009 Earnings Guidance
6. WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development
7. Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals
8. Markel Corporation Announces New DataBreach(SM) Privacy Liability Coverage
9. Allscripts Announces Expiration of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024
10. Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt
11. Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia ... the company,s second affiliate in Latin America . ... ... Farma Colombia ... ...
Breaking Medicine Technology: